The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/85321
Kemwell Biopharma Bangalore, India www.kemwellbiopharma.com (919) 397-3000 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, & phase 3) Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, capsules, controlled substances, creams & ointments, gels, generics, injectables, liquids, lyophilized products, non-sterile, ophthalmics, OTC, parenterals (small volume), peptides, powders (non-sterile), proteins, semisolids, solid dose, solutions & suspensions, sterile, suppositories, sustained release, syringes (pre-filled), and topicals "In today's competitive marketplace, it's wonderful to hear positive customer & industry feedback like this. It tells us that we are on the right track. For over 30 years, Kemwell has maintained a strong history of manufacturing quality, flexibility, and customer service. We continuously try to improve on our model by investing in our staff and facilities to provide innovative solutions, in-line with our customers' needs and goals." — Anurag Bagaria, managing director & CEO Lyophilization Technology, Inc. Ivyland, PA www.Lyotechnology.com (215) 396-8373 DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Formulated Drug Production – dosage form development and dosage form production SERVICES OFFERED: Aseptic fill/finish, cartridges, controlled substances, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, ophthalmics, parenterals (large volume), parenterals (small volume), peptides, powders (sterile), proteins, solutions & suspensions, sterile, sustained release, syringes (pre-filled), and vaccines. "Lyophilization Technology is a group of experienced and knowledgeable scientists, technicians, and support staff focused on providing development, technical services and clinical supply manufacturing for lyophilized products. Closely collaborating with our clients, we see our mission as applying our capabilities and expertise to the challenges of developing new and innovative products. Thank you to all the survey respondents in bestowing LTI with the CMO Leadership Awards for quality, reliability, and productivity." — Edward H. Trappler, president 42 The CMO Leadership Awards 2012 Manufacturing location: Ivyland, PA Contact: Christine Adams cadams@lyo-t.com DRUG TYPE: Pharmaceuticals Manufacturing locations: Bangalore, India, and Uppsala, Sweden Contact: Christian Ahlmark Christian.ahlmark@kemwellpharma.com DRUG TYPE: Pharmaceuticals and Biopharmaceuticals Laureate Biopharmaceutical Services, Inc. Princeton, NJ www.LBioS.com (609) 919-3390 Manufacturing location: Princeton, NJ Contact: Lisa Cozza, vice president, business development lisa.cozza@LBioS.com DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development and dosage form production SERVICES OFFERED: Aseptic fill/finish, injectables, liquids, parenterals (large volume), parenterals (small volume), proteins, solutions & suspensions, and sterile. "Laureate Biopharma has 30 years of innovation in biopharmaceutical development and processing. We were early adopters of single- use technologies, chemically defined culture media, high-speed chromatographic resins and membranes. We work collaboratively with our clients and suppliers to produce quality protein therapeutics with modern, efficient processes using innovative materials and techniques." — Michael A. Griffith, chief executive officer NextPharma Technologies LTD Send, Surrey, England www.nextpharma.com +44 1483 479120 Manufacturing locations: France and Germany (Austrian and Swiss Logistic Centers) Contact: Pierre Delavaud pierre.delavaud@nextpharma.com DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Beta-lactams, capsules, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, hormone, humidity sensitive, liquids, non-sterile, opthalmics, OTC, peptides, powders (non-sterile), semisolids, soft gels, solid dose, solutions & suspensions, sustained release, and topicals. "Our strategy focuses on providing customer satisfaction, and pivotal to this is consistent compliance with regulatory standards. We work with our customers, in partnership, to ensure that quality is 'built in' to the products, processes and services that we offer. Our teams have a reputation for openness and transparency. Our culture of continuous improvement facilitates our desire to apply regulatory guidance in a way that benefits our customers, our business, and ensures continued regulatory success." — Dr. Franck Latrille, CEO DRUG LIFE CYCLE STAGES